Matinas BioPharma Registers for Shelf Offering of $200 Million Worth of Mixed Securities - (Fidelity via NewsPoints Desk)

  • Matinas BioPharma registered with the Securities and Exchange Commission for the shelf offering of stock, debt securities, warrants, units, and subscription rights worth up to $200 million, as reported Fidelity on Monday.

  • The company said it plans to use the proceeds for working capital and general corporate purposes.

To read more NewsPoints articles, click here.